4.8 Article

An autoimmune disease-associated CTLA-4 splice variant lacking the B7 binding domain signals negatively in T cells

Journal

IMMUNITY
Volume 20, Issue 5, Pages 563-575

Publisher

CELL PRESS
DOI: 10.1016/S1074-7613(04)00110-4

Keywords

-

Categories

Funding

  1. NIAID NIH HHS [P01 AI 39671, R01 AI4480] Funding Source: Medline
  2. NINDS NIH HHS [NS35685] Funding Source: Medline

Ask authors/readers for more resources

Cytotoxic T lymphocyte-associated antigen-4 (CTLA-4) plays a critical role in downregulating T cell responses. A number of autoimmune diseases have shown genetic linkage to the CTLA-4 locus. We have cloned and expressed an alternatively spliced form of CTLA-4 that has genetic linkage with type I diabetes in the NOD mice. This splice variant of CTLA-4, named ligand-independent CTLA-4 (liCTLA-4), lacks exon2 including the MYPPPY motif essential for binding to the costimulatory ligands B7-1 and B7-2. Here we show that liCTLA-4 is expressed as a protein in primary T cells and strongly inhibits T cell responses by binding and dephosphorylating the TcRzeta chain. Expression of liCTLA-4, but not full-length CTLA-4 (fICTLA-4), was higher in memory/regulatory T cells from diabetes-resistant NOD congenic mice compared to susceptible NOD mice. These data suggest that increased expression and negative signaling delivered by the liCTLA-4 may regulate development of T cell-mediated autoimmune diseases.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available